We are live on ! Find out more

3,190 hedge funds and large institutions have $187B invested in Abbott in 2025 Q2 according to their latest regulatory filings, with 180 funds opening new positions, 1,324 increasing their positions, 1,227 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 180 | Existing positions closed: 120

25% more call options, than puts

Call options by funds: $1.37B | Put options by funds: $1.1B

8% more repeat investments, than reductions

Existing positions increased: 1,324 | Existing positions reduced: 1,227

3% more capital invested

Capital invested by funds: $182B → $187B (+$5.01B)

0% more funds holding

Funds holding: 3,1773,190 (+13)

0.12% less ownership

Funds ownership: 79.24%79.12% (-0.12%)

16% less funds holding in top 10

Funds holding in top 10: 11698 (-18)

Holders
3,190
Holders Change
+13
Holders Change %
+0.41%
% of All Funds
41.9%
Holding in Top 10
98
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-15.52%
% of All Funds
1.29%
New
180
Increased
1,324
Reduced
1,227
Closed
120
Calls
$1.37B
Puts
$1.1B
Net Calls
+$270M
Net Calls Change
+$67.3M

ABT Hedge Fund Activity: Q2 2025 in Review

3,190 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Abbott (ABT) for Q2 2025, worth a combined $187B — up 2.8% from $182B a quarter earlier.

Buyers outnumbered sellers: 180 funds opened new ABT positions and 120 closed out — a net gain of 60 holders — while 1,324 added to existing stakes and 1,227 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $815M. The largest seller was Capital Research Global Investors, cutting an estimated $1.18B.

  • 3,190 institutional investors held Abbott (ABT) as of Q2 2025, up from 3,177 in Q1 2025.
  • Funds reported $187B of Abbott stock for Q2 2025, up 2.8% quarter-over-quarter.
  • 180 funds opened new Abbott positions in Q2 2025 and 120 closed out, a net change of +60 holders.
  • The largest Abbott buyer in Q2 2025 was T. Rowe Price Associates, an estimated $815M added.
  • The largest Abbott seller in Q2 2025 was Capital Research Global Investors, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2025.